Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3125last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.53d agoneutral
Novavax (NVAX) Could Be 32% Above Fair Value On Medicare Policy FearsSimply Wall St.53d agobullish
Do Novavax’s (NVAX) New Partnerships Offset Policy Risks From The Protecting Approved Care Act?MarketBeat59d agoneutral
Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform PivotMarketBeat60d agoneutral
Novavax Highlights Matrix-M Licensing Push, Oncology Ambitions at Cantor ConferenceStockStory66d agoneutral
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds24/7 Wall St.68d agobullish
Novavax Jumps 6% on Matrix-M Oncology Speculation: Is the Royalty Model the Real Story?Simply Wall St.71d agoneutral
How Expanded Nuvaxovid Royalties and Partner-led Execution Could Shape Novavax’s (NVAX) Investment NarrativeSimply Wall St.71d agoneutral
Novavax (NVDA) Following Updated Nuvaxovid Approval Faces A Wide Fair Value DebateStocktwits72d agobullish
NVAX Stock Climbs As Partnership Model Keeps COVID Vaccine Cash Flow OpenSchaeffer's Investment Research74d agoneutral
Novavax Stock Pulls Back After Milestone Vaccine SuccessStockStory74d agoneutral
Unpacking Q2 Earnings: Novavax (NASDAQ:NVAX) In The Context Of Other Therapeutics StocksBarchart79d agobullish
NVAX Stock Alert: Biotechs Hit Post-Pandemic High on mRNA Cancer BreakthroughBarrons.com81d agobullish
BioNTech Stock Surges 20% on Moderna Cancer Vaccine Win. Why the Gains Could Fade.